Stocks and Investing
Stocks and Investing
Thu, February 29, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $5 on, Feb 29th, 2024
Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $5 on, Feb 29th, 2024.
Gil has made no other calls on TSHA in the last 4 months.
There is 1 other peer that has a rating on TSHA. Out of the 1 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gil
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Monday, December 18th, 2023
Contributing Sources